United Therapeutics Corp
(NAS:UTHR)
$
264.63
-1.42 (-0.53%)
Market Cap: 11.74 Bil
Enterprise Value: 9.69 Bil
PE Ratio: 12.51
PB Ratio: 2.19
GF Score: 89/100 United Therapeutics Corp at TD Cowen Health Care Conference Transcript
Mar 05, 2024 / 05:50PM GMT
Release Date Price:
$229.81
(+0.47%)
Joseph John;Charles Thome
TD Cowen, Research Division - MD & Senior Research Analyst
44th Annual TD Cowen Healthcare Conference. I'm Joe Thome, I'm one of the senior biotech analyst here on the team at TD Cowen. And it's my pleasure to have with me today the team from United Therapeutics. We have President and COO, Mike Benkowitz and CFO and Treasurer, James Edgemond. Thank you both for joining us.
Questions & Answers
Joseph John;Charles Thome
TD Cowen, Research Division - MD & Senior Research Analyst
So maybe just to start things off, congrats on the record revenues in 2023. Maybe just give us a brief overview of the company's recent progress and your outline goals for the rest of this year?
Michael I. Benkowitz
United Therapeutics Corporation - President & COO
Sure. Thanks, Joe, and thanks for hosting us today. Before I get started, my lawyers would want me to say something about forward-looking statements. So there you go. You guys can check out our
Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot